Cargando…

Uterine Adenosarcoma: A Retrospective 12-Year Single-Center Study

Synopsis: Lymphovascular space invasion is an independent risk factor for disease progression and presence of tumor stalk an independent protective factor. Fertility sparing surgery may be acceptable in cases whose tumors present with stalks and without high risk factors. Objectives: The aim of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Zhen, Yu, Mei, Shen, Keng, Yang, Jiaxin, Cao, Dongyan, Zhang, Ying, Zhou, Huimei, Wu, Huanwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527837/
https://www.ncbi.nlm.nih.gov/pubmed/31139558
http://dx.doi.org/10.3389/fonc.2019.00237
_version_ 1783420094810947584
author Yuan, Zhen
Yu, Mei
Shen, Keng
Yang, Jiaxin
Cao, Dongyan
Zhang, Ying
Zhou, Huimei
Wu, Huanwen
author_facet Yuan, Zhen
Yu, Mei
Shen, Keng
Yang, Jiaxin
Cao, Dongyan
Zhang, Ying
Zhou, Huimei
Wu, Huanwen
author_sort Yuan, Zhen
collection PubMed
description Synopsis: Lymphovascular space invasion is an independent risk factor for disease progression and presence of tumor stalk an independent protective factor. Fertility sparing surgery may be acceptable in cases whose tumors present with stalks and without high risk factors. Objectives: The aim of the present study was to investigate the potential prognostic factors of uterine adenosarcoma. Methods: A total of 49 cases of uterine adenosarcoma were retrospectively reviewed at our institution between April 2006 and October 2018. Results: Median follow-up time was 34 months (range: 1–148). Median age was 47.50 years (19–75). Nineteen (38.9%) patients were uterine cervical adenosarcoma and 30 (61.22%) patients were uterine corpus adenosarcoma. Twenty-nine (59.2%) patients were polypoid with a stalk to the uterine cervix or corpus. Twenty-six (38.8%) patients were stage IA. Fifteen (30.6%) patients showed sarcomatous overgrowth. Six (12.2%) patients displayed lymphovascular space invasion (LVSI). Four (8.16%) patients had heterologous elements. In univariate analysis, Disease-free-survival (DFS) was associated with tumor location, presence of tumor stalk, heterologous elements, LVSI. In multivariate analysis, presence of tumor stalk remained an independently protective factor for recurrence (HR = 0.088, P = 0.005), and LVSI a risk factor for recurrence (HR = 11.953, P = 0.002). Fertility-sparing surgery (FSS) was performed in seven stage IA patients. When patients of stage IA analyzed separately, FSS was not significant with the DFS or OS. Conclusions: Presence of tumor stalk remained an independently protective factor for recurrence. Along with adequate counseling, FSS may be acceptable in cases whose tumors present with stalks and without high risk factors.
format Online
Article
Text
id pubmed-6527837
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-65278372019-05-28 Uterine Adenosarcoma: A Retrospective 12-Year Single-Center Study Yuan, Zhen Yu, Mei Shen, Keng Yang, Jiaxin Cao, Dongyan Zhang, Ying Zhou, Huimei Wu, Huanwen Front Oncol Oncology Synopsis: Lymphovascular space invasion is an independent risk factor for disease progression and presence of tumor stalk an independent protective factor. Fertility sparing surgery may be acceptable in cases whose tumors present with stalks and without high risk factors. Objectives: The aim of the present study was to investigate the potential prognostic factors of uterine adenosarcoma. Methods: A total of 49 cases of uterine adenosarcoma were retrospectively reviewed at our institution between April 2006 and October 2018. Results: Median follow-up time was 34 months (range: 1–148). Median age was 47.50 years (19–75). Nineteen (38.9%) patients were uterine cervical adenosarcoma and 30 (61.22%) patients were uterine corpus adenosarcoma. Twenty-nine (59.2%) patients were polypoid with a stalk to the uterine cervix or corpus. Twenty-six (38.8%) patients were stage IA. Fifteen (30.6%) patients showed sarcomatous overgrowth. Six (12.2%) patients displayed lymphovascular space invasion (LVSI). Four (8.16%) patients had heterologous elements. In univariate analysis, Disease-free-survival (DFS) was associated with tumor location, presence of tumor stalk, heterologous elements, LVSI. In multivariate analysis, presence of tumor stalk remained an independently protective factor for recurrence (HR = 0.088, P = 0.005), and LVSI a risk factor for recurrence (HR = 11.953, P = 0.002). Fertility-sparing surgery (FSS) was performed in seven stage IA patients. When patients of stage IA analyzed separately, FSS was not significant with the DFS or OS. Conclusions: Presence of tumor stalk remained an independently protective factor for recurrence. Along with adequate counseling, FSS may be acceptable in cases whose tumors present with stalks and without high risk factors. Frontiers Media S.A. 2019-05-14 /pmc/articles/PMC6527837/ /pubmed/31139558 http://dx.doi.org/10.3389/fonc.2019.00237 Text en Copyright © 2019 Yuan, Yu, Shen, Yang, Cao, Zhang, Zhou and Wu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Yuan, Zhen
Yu, Mei
Shen, Keng
Yang, Jiaxin
Cao, Dongyan
Zhang, Ying
Zhou, Huimei
Wu, Huanwen
Uterine Adenosarcoma: A Retrospective 12-Year Single-Center Study
title Uterine Adenosarcoma: A Retrospective 12-Year Single-Center Study
title_full Uterine Adenosarcoma: A Retrospective 12-Year Single-Center Study
title_fullStr Uterine Adenosarcoma: A Retrospective 12-Year Single-Center Study
title_full_unstemmed Uterine Adenosarcoma: A Retrospective 12-Year Single-Center Study
title_short Uterine Adenosarcoma: A Retrospective 12-Year Single-Center Study
title_sort uterine adenosarcoma: a retrospective 12-year single-center study
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527837/
https://www.ncbi.nlm.nih.gov/pubmed/31139558
http://dx.doi.org/10.3389/fonc.2019.00237
work_keys_str_mv AT yuanzhen uterineadenosarcomaaretrospective12yearsinglecenterstudy
AT yumei uterineadenosarcomaaretrospective12yearsinglecenterstudy
AT shenkeng uterineadenosarcomaaretrospective12yearsinglecenterstudy
AT yangjiaxin uterineadenosarcomaaretrospective12yearsinglecenterstudy
AT caodongyan uterineadenosarcomaaretrospective12yearsinglecenterstudy
AT zhangying uterineadenosarcomaaretrospective12yearsinglecenterstudy
AT zhouhuimei uterineadenosarcomaaretrospective12yearsinglecenterstudy
AT wuhuanwen uterineadenosarcomaaretrospective12yearsinglecenterstudy